PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31567972-7	2019	Combined therapy with 5-ASA + Adalimumab led to the strongest changes in marker modulation: IL-4, IL-5, IL-15, and PDGF-BB, were upregulated (P < .05).Elevated serum levels of G-CSF, IL-1Ra, and PDGF-BB were associated with IBD endoscopic activity, and of IP-10 with extraintestinal manifestations of IBD.	Mesalamine	22-27	C-X-C motif chemokine ligand 10	Homo sapiens	259-264	
30478770-7	2019	Multiple linear regression models predicted significant association between transcript levels of Ki-67, NF-kB (p65), PPARgamma, COX-2 and IL-8, CDC25A, and CXCL10 with duration of drug (5-ASA) exposure (P <= 0.05).	Mesalamine	186-191	C-X-C motif chemokine ligand 10	Homo sapiens	156-162